NYSEARCA:IDNA

iShares Genomics Immunology and Healthcare ETF (IDNA) Price, Holdings, & News

$22.03
+0.32 (+1.47%)
(As of 04/22/2024 ET)
Today's Range
$21.79
$22.21
50-Day Range
$21.71
$25.20
52-Week Range
$17.33
$25.52
Volume
20,566 shs
Average Volume
42,520 shs
Market Capitalization
$128.88 million
Assets Under Management
$127.07 million
Dividend Yield
0.64%
Net Expense Ratio
0.47%

About iShares Genomics Immunology and Healthcare ETF

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.

IDNA Stock Price History

IDNA ETF News Headlines

iShares Genomics Immunology and Healthcare ETF (IDNA)
IDNA: Healthcare Dashboard For February
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
IBRN iShares Neuroscience and Healthcare ETF
IDNA ETF Stock Price History
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
IBDT iShares iBonds Dec 2028 Term Corporate ETF
See More Headlines
Receive IDNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Genomics Immunology and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
iShares
Fund Name
iShares Genomics Immunology and Healthcare ETF
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:IDNA
Inception Date
6/11/2019
Fund Manager
Jennifer Hsui, Greg Savage, Paul Whitehead
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
NYSE FactSet Global Genomics and Immuno Biopharma Index
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
63

Fund Statistics

Assets Under Management
$127.07 million
Average Daily Volume
$0.00
Discount/Premium
-0.01%

Administrator, Advisor and Custodian

Administrator
State Street Bank and Trust Company
Advisor
BlackRock Fund Advisors
Custodian
State Street Bank and Trust Company
Distributor
BlackRock Investments, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
N/A
Short Interest
30,900 shs

Miscellaneous

Beta
1.06
Creation Unit
50,000
Creation Fee
$850.00
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

iShares Genomics Immunology and Healthcare ETF Expenses

TypeIDNATheme ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.47%0.57%0.54%0.50%0.51%
Other Expenses0.00%0.72%0.54%0.64%0.58%
Total Expense0.47%0.72%0.70%0.74%0.70%
Fee Waiver0.00%-0.76%-0.55%-0.68%-0.57%
Net Expense0.47%0.59%0.60%0.57%0.58%

iShares Genomics Immunology and Healthcare ETF (IDNA) Holdings & Exposure

IDNA Sector Exposure

IDNA Industry Exposure


IDNA ETF - Frequently Asked Questions

How have IDNA shares performed in 2024?

iShares Genomics Immunology and Healthcare ETF's stock was trading at $23.01 on January 1st, 2024. Since then, IDNA shares have decreased by 4.3% and is now trading at $22.03.
View the best growth stocks for 2024 here
.

What does IDNA invest in?

iShares Genomics Immunology and Healthcare ETF is a equity fund issued by iShares. IDNA focuses on theme investments and follows the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund's investments total to approximately $127.07 million assets under management.

What stocks does iShares Genomics Immunology and Healthcare ETF hold?
What is the management fee for iShares Genomics Immunology and Healthcare ETF?

iShares Genomics Immunology and Healthcare ETF's management fee is 0.47% and has no other recorded expenses or fee waivers. The net expense ratio for IDNA is 0.47%.

What other stocks do shareholders of iShares Genomics Immunology and Healthcare ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Genomics Immunology and Healthcare ETF investors own include Pfizer (PFE), Gilead Sciences (GILD), Intel (INTC), AbbVie (ABBV), Inovio Pharmaceuticals (INO), Novavax (NVAX), Canadian Natural Resources (CNQ), QUALCOMM (QCOM), SPDR S&P Biotech ETF (XBI) and Bristol-Myers Squibb (BMY).

How do I buy shares of iShares Genomics Immunology and Healthcare ETF?

Shares of IDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEARCA:IDNA) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners